Vol. 16 No. 3 (2012)
REVIEWS

Risk factors and strategies for stroke prevention in low to middle-income countries

PDF (Русский)
  • V. Feygin,
  • R. Krishnamurzi
V. Feygin
National Institute for Stroke and Applied Neurosciences, Auckland University of Technology
Bio
R. Krishnamurzi
National Institute for Stroke and Applied Neurosciences, Auckland University of Technology
Bio
DOI: https://doi.org/10.21688/1681-3472-2012-3-83-84

Published 2012-09-25

Keywords

  • STROKE,
  • PREVENTION,
  • LOW TO MIDDLE INCOME COUNTRIES

How to Cite

Feygin, V., & Krishnamurzi, R. (2012). Risk factors and strategies for stroke prevention in low to middle-income countries. Patologiya Krovoobrashcheniya I Kardiokhirurgiya, 16(3), 83–84. https://doi.org/10.21688/1681-3472-2012-3-83-84

Copyright (c) 2012 Feygin V.L., Krishnamurzi R.

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Abstract

A recent meta-analysis of the population-based stroke incidence studies showed a significant trend towards almost 2-fold increasing of stroke incidence rates in low to middle-income countries over the last 4 decades. The study also demonstrated that stroke incidence rates in low to middle-income countries currently exceed the level of stroke incidence in the developed (high income) countries by 20%. Compared with people in high-income countries, people in low to middle-income countries also experience a higher stroke mortality rate and greater proportions of hemorrhagic strokes. Should the current trends in stroke incidence and aging of the population continue, deaths from stroke in the developing countries will increase over the next decade by 20% and the overall burden of stroke may soon become unbearable for the economy of these countries. The way to stop the stroke pandemic and reduce stroke incidence is effective stroke prevention. In this review, we summarize current evidence for stroke risk factors and prevention in low to middle-income countries and outline possible promising strategies for tackling the problem.
PDF (Русский)

References

  1. O'Donnell M.J., Xavier D., Liu L. et al. // Lancet. V. 376. Р. 112-123.
  2. Strong K., Mathers C., Bonita R. // Lancet Neurology. 2007. V. 6. Р. 182-187.
  3. Ezzati M., Hoorn S.V., Lopez D.A. Global Burden of Disease and Risk Factors. New York, 2006. Р. 241-268.
  4. Blood pressure, cholesterol, and stroke in eastern Asia. Eastern Stroke and Coronary Heart Disease Collaborative Research Group // Lancet. 1998. V. 352. Р. 1801-1807.
  5. Thorogood M., Connor M., Tollman S. et al. // BMC Public Health. 2007. V. 7. Р. 326.
  6. Connor M.D., Thorogood M., Modi G. et al. // American J. Preventive Medicine. 2007. V. 33. Р. 172-173.
  7. Singh R.B., Suh I.L., Singh V.P. et al. // J. Human Hypertension. 2000. V. 14. Р. 749-763.
  8. Thrift A.G., Srikanth V., Fitzgerald S.M. et al. // Clin. Exp. Pharmacol. Physiol. 2010. V. 37. Р. e78-e90.
  9. Lloyd-Sherlock P. // Development Policy Review. V. 28. Р. 693-709.
  10. Feigin V.L., Krishnamurthi R. // Stroke. 2011. V. 42. Р. 3655-3658.
  11. Gomez G.B., Cappuccio F.P. // Current Medicinal Chemistry: Immunology, Endocrine Metabolic Agents. 2005. V. 5. Р. 13-20.
  12. Chaloupka F.J., Straif K., Leon M.E. // Tobacco Control. 2011. V. 20 (3). Р. 235-238.
  13. Li Y., Liu J., Song D. et al. // J. Hypertens. 2007. V. 25. Р. 2011-2018.
  14. Yusuf S., Reddy S., Ounpuu S., Anand S. // Circulation. 2001. V. 104. Р. 2855-2864.
  15. Poungvarin N. // Int. J. Stroke. 2007. V. 2. Р. 127-128.
  16. Feigin V.L., Lawes C.M., Bennett D.A. et al. // Lancet Neurology. 2009. V. 8. Р. 355-369.
  17. Johnston S.C., Mendis S., Mathers C.D. et al. // Lancet Neurology. 2009. V. 8. Р. 345-354.
  18. Feigin V.L. // Lancet Neurology. 2007. V. 6. Р. 94-97.
  19. Ebrahim S., Smith G.D. // International J. Epidemiology. 2001. V. 30. Р. 201-205.
  20. Puska P. // International J. Epidemiology. 2001. V. 30. Р. 1493-1494.